Who should avoid GLP-1 weight loss medication in Miami?
Some medical histories rule out particular medicines; others need further evaluation. This guide explains those differences for Miami readers. Miami Weight Loss provides information, while a prescribing clinician decides whether a treatment is appropriate.
Medical histories that can rule out specific GLP-1 medicines
The safety review starts with the exact medicine. Wegovy weight loss medication and Zepbound weight loss medication must not be used by people with a personal or family history of medullary thyroid carcinoma, or people who have multiple endocrine neoplasia syndrome type 2. These terms refer to specific conditions. If relatives have mentioned thyroid disease, ask which diagnosis they mean and bring that information to the appointment.
A previous serious allergic reaction to a medicine or its ingredients is another reason that product may be ruled out. Record the product name, symptoms and treatment received. Feeling nauseated is different from having a serious allergy, although either deserves an accurate history. The overview of GLP-1 side effects helps separate questions about tolerability from the need for medical attention.
Wegovy and Zepbound are not recommended for people with severe gastroparesis. A lower starting dose does not remove that warning. Before arranging physician-supervised weight loss care, tell the provider about diagnosed delayed stomach emptying and any specialist evaluation. A clinician needs the diagnosis and current symptoms to explain whether another approach should be considered.
Absolute
The screening
What the screening actually asks
Family history
Thyroid cancer and endocrine syndromes in particular. If you are unsure, it is worth asking relatives before the appointment rather than guessing.
Personal history
Pancreatitis, gallbladder disease, severe gastrointestinal conditions and any previous reaction to a GLP-1.
Current medication
Especially diabetes treatment, thyroid medication and anything with strict absorption timing.
Pregnancy and planning
Whether pregnancy is possible now or planned, and what contraception is in place.
Care, not exclusion
Pregnancy and other factors in weight loss medication safety
Pregnancy changes the treatment decision. Wegovy used for weight reduction and Zepbound should be discontinued when pregnancy is recognized; contact the prescriber promptly. Planned pregnancy and breastfeeding need advice for the particular product and formulation. Weight loss care for women includes questions to raise about reproductive plans. Bring your contraception details as well as other prescriptions to a weight loss eligibility assessment rather than assuming every GLP-1 medicine has the same instructions.
Previous pancreatic or gallbladder disease, kidney problems and other medicines also belong in that conversation. They do not support a blanket promise that treatment is safe with slower dose increases. The provider may need old records, additional assessment or a different option. Our weight-related health conditions guide explains why a diagnosis can matter to the treatment discussion, while prescription weight loss medications describes the available categories. A useful decision explains both the reason for treatment and the risks that could change it.
Previous poor reactionSlower titration
Pancreas or gallbladderCloser watch
GI conditionsCase by case
Safety
The rest of the safety picture
Side effects, interactions and what to do about each.
Questions about GLP-1 exclusions and individual safety reviews
Specific diagnoses, previous reactions and information to bring to a prescribing appointment.
Tell the clinician which details you know and which you cannot confirm. Avoid guessing about a relative's cancer type. A provider can explain whether records or further evaluation would help before making a prescribing decision. General weight loss eligibility guidance cannot resolve an uncertain family history.
Nausea alone does not establish a drug allergy. Tell the prescriber exactly what happened and whether there was a rash, swelling, breathing trouble or emergency treatment. The common GLP-1 side effects guide covers everyday symptoms. Do not retry a medicine after a suspected serious allergic reaction without medical evaluation.
Yes. Meeting a weight threshold does not establish that a particular drug is suitable. The BMI requirements for weight loss are one part of assessment. Contraindications, other medicines, reproductive plans and your current health can change the recommendation.
Yes. Tell both the prescriber and the team arranging anesthesia or deep sedation about any GLP-1 medicine you take or plan to start. Delayed stomach emptying can affect procedure planning. Ask for individualized instructions rather than choosing your own stopping interval.
No. Information on this site cannot clear someone for treatment or replace a clinician's assessment. A free weight loss inquiry also does not establish medical suitability. Bring your questions and records to the healthcare professional responsible for the prescription.
